chartexchange

PRLD
Prelude Therapeutics Incorporated
stockNASDAQ

Market OpenNov 19, 2026 3:32:19 PM EST
3.23USD-2.121%(-0.07)146,149
3.2500Bid3.2700Ask0.0200Spread

PRLD Financials

In Q3 FY 2026 (ended ), Prelude Therapeutics Incorporated (PRLD) reported revenue of $5.65M, net income of −$12.54M, operating cash flow of −$13.78M, and assets of $175.49M (filed ).

Loading financial statements…